Publication | Closed Access

Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Hematological MalignancyOncologyMaintenance TreatmentMedicineHematologyClinical TrialsMyeloid NeoplasiaJoint Hovon-50/gmmg-hd3PharmacotherapyPharmacologyMyeloma PatientsHealth Sciences